ZBH

#614
Zimmer Biomet Holdings, Inc.
96.8600 USD
+2.23%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
96.3700
97.1600
Годовой диапазон
84.5900
103.6900
Дневное изменение
+2.23%
Месячное изменение
+3.04%
6-месячное изменение
-6.42%
Годовое изменение
-6.42%
Предыдущее закрытие
94.7450
Открыть
96.4350
Bid
Ask
Минимум
96.3700
High
97.1600
Объем
133
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 18.9509 B
  • Employee 17 K
  • Founded N/A
  • CEO Ivan Tornos
  • Website www.zimmerbiomet.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKPL53
  • Industry Technology
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
25.33
Коэффициент цена/денежный поток
2.25
Дивиденды на акцию
0.96
Дивидендная доходность, %
1.07

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.

Новости